ヨーロッパの特殊ジェネリック市場予測2021年-2026年

【英語タイトル】Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

IMARCが出版した調査資料(IMA21SE295)・商品コード:IMA21SE295
・発行会社(調査会社):IMARC
・発行日:2021年5月
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:ヨーロッパ
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD1,999 ⇒換算¥295,852見積依頼/購入/質問フォーム
Five UserUSD2,999 ⇒換算¥443,852見積依頼/購入/質問フォーム
EnterprisewideUSD3,999 ⇒換算¥591,852見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

本書では、特殊ジェネリックのヨーロッパ市場を調査対象とし、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、特殊ジェネリックが収益性がある理由、世界の特殊ジェネリック市場、投与経路別分析、疾患別分析、流通チャネル別分析、地域別分析、競争状況などを整理しました。

Europe specialty generics market reached a value of US$ 16.4 Billion in 2020. Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc.
Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions. Unlike branded speciality drugs, specialty generics don’t require expensive and time-consuming research and development procedures. Additionally, they also don’t incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market. Looking forward, IMARC Group expects the Europe specialty generics market to exhibit strong growth during the next five years.

Market Scope:

Historical, Current and Future Market Trends

Market Breakup by Region:

Italy
Germany
France
United Kingdom
Spain
Rest of Europe

Market Breakup by Route of Administration:

Injectables
Oral
Others

Market Breakup by Indication:

Oncology
Autoimmune Diseases
Infectious Diseases
Others

Market Breakup by Distribution Channel:

Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies

Competitive Landscape:

The leading players in the European specialty generics industry have also been examined in the report.

Key Questions Answered in This Report:

How has the European specialty generics market performed so far and how will it perform in the coming years?
What is the breakup of the European specialty generics market based on the region?
What has been the impact of COVID-19 on the European specialty generics market?
What is the breakup of the European specialty generics market based on the route of administration?
What is the breakup of the European specialty generics market based on the indication?
What is the breakup of European specialty generics market based on the distribution channel?
What are the various stages in the value chain of the specialty generics industry?
What are the key driving factors and challenges in the European specialty generics market?
What is the structure of the European specialty generics industry and who are the key players?
What is the degree of competition in the European specialty generics market

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Specialty Generics Market: Introduction
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics
5 Why are Specialty Generics So Lucrative?
6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Indication
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast
7 Europe Specialty Generics Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Route of Administration
7.5 Market Breakup by Indication
7.6 Market Breakup by Distribution Channel
7.7 Market Breakup by Region
7.8 Market Forecast
7.9 SWOT Analysis
7.9.1 Overview
7.9.2 Strengths
7.9.3 Weaknesses
7.9.4 Opportunities
7.9.5 Threats
7.10 Value Chain Analysis
7.11 Porters Five Forces Analysis
7.11.1 Overview
7.11.2 Bargaining Power of Buyers
7.11.3 Bargaining Power of Suppliers
7.11.4 Degree of Competition
7.11.5 Threat of New Entrants
7.11.6 Threat of Substitutes
7.12 Key Market Drivers and Success Factors
8 Market Breakup by Route of Administration
8.1 Injectable
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Indication
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Autoimmune Diseases
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Infectious Diseases
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Retail Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospital Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 Italy
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Germany
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 France
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 United Kingdom
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Spain
11.5.1 Market Trends
11.5.2 Market Forecast
11.6 Rest of Europe
11.6.1 Market Trends
11.6.2 Market Forecast
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players

Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2020
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 8: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 9: Europe: Specialty Generics Market: Breakup by Indication (in %), 2020
Figure 10: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 11: Europe: Specialty Generics Market: Breakup by Region (in %), 2020
Figure 12: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 13: Europe: Specialty Generics Industry: SWOT Analysis
Figure 14: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 15: Europe: Specialty Generics Market (Administration Through Injectables): Sales Value (in Million US$), 2015 & 2020
Figure 16: Europe: Specialty Generics Market (Administration Through Injectables) Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2015 & 2020
Figure 18: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2015 & 2020
Figure 20: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Europe: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2015 & 2020
Figure 22: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Million US$), 2015 & 2020
Figure 24: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Million US$), 2015 & 2020
Figure 26: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Europe: Specialty Generics Market (Other Indications): Sales Value (in Million US$), 2015 & 2020
Figure 28: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Europe: Specialty Generics Market: Sales Through Retail Pharmacies (in Million US$), 2015 & 2020
Figure 30: Europe: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Million US$), 2021-2026
Figure 31: Europe: Specialty Generics Market: Sales Through Specialty Pharmacies (in Million US$), 2015 & 2020
Figure 32: Europe: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Million US$), 2021-2026
Figure 33: Europe: Specialty Generics Market: Sales Through Hospital Pharmacies (in Million US$), 2015 & 2020
Figure 34: Europe: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Million US$), 2021-2026
Figure 35: Italy: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Germany: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: France: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Spain: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Rest of Europe: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026

Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 3: Europe: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: Europe: Specialty Generics Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 5: Europe: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Europe: Specialty Generics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Europe: Specialty Generics Market Structure
Table 8: Europe: Specialty Generics Market: Key Players

★調査レポート[ヨーロッパの特殊ジェネリック市場予測2021年-2026年] (コード:IMA21SE295)販売に関する免責事項を必ずご確認ください。
★調査レポート[ヨーロッパの特殊ジェネリック市場予測2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆